Xcelerate Inc. (XCRT)
OTCMKTS · Delayed Price · Currency is USD
0.0117
-0.0003 (-2.51%)
Oct 27, 2025, 12:26 PM EDT
Xcelerate Market Cap
Xcelerate has a market cap or net worth of $5.19 million as of October 27, 2025. Its market cap has decreased by -45.31% in one year.
Market Cap
5.19M
Enterprise Value
6.67M
Revenue
2.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since January 25, 2005, Xcelerate's market cap has decreased from 22.60M to 5.19M, a decrease of -77.03%. That is a compound annual growth rate of -6.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 5.19M | -45.31% |
| Dec 31, 2024 | 9.49M | -39.27% |
| Dec 29, 2023 | 15.63M | 17.08% |
| Dec 30, 2022 | 13.35M | -56.33% |
| Dec 31, 2021 | 30.57M | 156.06% |
| Dec 31, 2020 | 11.94M | 4,707.39% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 319.35M |
| American Oncology Network | 291.52M |